心房颤动患者在不同血清地高辛浓度下的运动心率。
Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.
作者信息
Beasley R, Smith D A, McHaffie D J
出版信息
Br Med J (Clin Res Ed). 1985 Jan 5;290(6461):9-11. doi: 10.1136/bmj.290.6461.9.
Abstract
Heart rate at rest and during increasing workloads was measured in a double blind study of 12 patients with chronic atrial fibrillation when serum concentrations of digoxin were nil and at low and high therapeutic values. Twelve normal subjects were studied for comparison. The heart rate at all levels of exercise in most patients with atrial fibrillation was not adequately controlled by any serum digoxin concentration tested despite a reduction in heart rate with increasing serum digoxin concentrations. Control of the resting heart rate, even in patients with high serum digoxin concentrations, did not ensure adequate control of the heart rate during work rates equivalent to regular daily activities.
摘要
在一项双盲研究中，对12例慢性心房颤动患者在血清地高辛浓度为零、低治疗值和高治疗值时静息及负荷增加时的心率进行了测量。选取12名正常受试者作为对照。尽管随着血清地高辛浓度升高心率有所降低，但大多数心房颤动患者在任何测试的血清地高辛浓度下，其在所有运动水平时的心率均未得到充分控制。即使是血清地高辛浓度较高的患者，静息心率得到控制也不能确保在相当于日常常规活动的工作强度下心率得到充分控制。
相似文献
1
Exercise heart rates at different serum digoxin concentrations in patients with atrial fibrillation.心房颤动患者在不同血清地高辛浓度下的运动心率。
Br Med J (Clin Res Ed). 1985 Jan 5;290(6461):9-11. doi: 10.1136/bmj.290.6461.9.
2
Influence of physical exercise on serum digoxin concentration and heart rate in patients with atrial fibrillation.体育锻炼对心房颤动患者血清地高辛浓度及心率的影响。
Br Heart J. 1991 Jun;65(6):337-41. doi: 10.1136/hrt.65.6.337.
3
Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.口服维拉帕米与地高辛单独及联合应用治疗慢性心房颤动患者的相对疗效
Clin Sci (Lond). 1988 Apr;74(4):351-7. doi: 10.1042/cs0740351.
4
Effect of Corwin (ICI 118587) on resting and exercise heart rate and exercise tolerance in digitalised patients with chronic atrial fibrillation.考温（ICI 118587）对慢性房颤洋地黄化患者静息及运动心率和运动耐量的影响。
Br Heart J. 1984 Oct;52(4):392-5. doi: 10.1136/hrt.52.4.392.
5
6
Low- and medium-dose diltiazem in chronic atrial fibrillation: comparison with digoxin and correlation with drug plasma levels.慢性心房颤动中低剂量和中剂量地尔硫䓬：与地高辛比较及与药物血浆水平的相关性
Am Heart J. 1988 Aug;116(2 Pt 1):385-92. doi: 10.1016/0002-8703(88)90610-2.
7
Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.口服维拉帕米治疗慢性心房颤动优于地高辛。
Chest. 1983 Mar;83(3):491-9. doi: 10.1378/chest.83.3.491.
8
[Comparison between digoxin and atenolol in chronic atrial fibrillation].
Rev Med Chil. 1995 Oct;123(10):1252-62.
9
The effects of digoxin and beta-methyldigoxin on the heart rate of decompensated patients with atrial fibrillation.地高辛和β-甲基地高辛对失代偿性房颤患者心率的影响。
Eur J Clin Invest. 1977 Feb;7(1):3-6. doi: 10.1111/j.1365-2362.1977.tb01562.x.
10
Effects of nadolol on the spontaneous and exercise-provoked heart rate of patients with chronic atrial fibrillation receiving stable dosages of digoxin.
Am Heart J. 1984 Oct;108(4 Pt 2):1121-7. doi: 10.1016/0002-8703(84)90592-1.
引用本文的文献
1
Management of atrial fibrillation in rheumatic heart disease.风湿性心脏病中房颤的管理
Heart Rhythm O2. 2022 Dec 16;3(6Part B):752-759. doi: 10.1016/j.hroo.2022.09.020. eCollection 2022 Dec.
2
[Rate versus rhythm control with and without heart failure].[伴或不伴心力衰竭时的心率控制与节律控制]
Herz. 2008 Dec;33(8):568-79. doi: 10.1007/s00059-008-3181-6.
3
Rate control in the medical management of atrial fibrillation.心房颤动医学管理中的心率控制
Heart. 2007 Jan;93(1):35-8. doi: 10.1136/hrt.2006.099903. Epub 2006 Sep 4.
4
Atrial fibrillation: how to approach rate control.心房颤动：如何进行心率控制。
Curr Cardiol Rep. 2005 Sep;7(5):391-7. doi: 10.1007/s11886-005-0094-3.
5
Computational approaches to structural and functional analysis of plastocyanin and other blue copper proteins.质体蓝素及其他蓝色铜蛋白结构与功能分析的计算方法。
Cell Mol Life Sci. 2004 May;61(10):1123-42. doi: 10.1007/s00018-004-3181-5.
6
Rate control in atrial fibrillation: choice of treatment and assessment of efficacy.心房颤动的心率控制：治疗选择与疗效评估
Drugs. 2003;63(14):1489-509. doi: 10.2165/00003495-200363140-00005.
7
New approaches to atrial fibrillation management: a critical review of a rapidly evolving field.心房颤动管理的新方法：对一个快速发展领域的批判性综述。
Drugs. 2002;62(16):2377-97. doi: 10.2165/00003495-200262160-00005.
8
Prevention of and medical therapy for atrial arrhythmias in heart failure.心力衰竭中心房性心律失常的预防与药物治疗
Heart Fail Rev. 2002 Jul;7(3):267-83. doi: 10.1023/a:1020097728178.
9
Pharmacological control of rate and maintenance of sinus rhythm.窦性心律的速率控制与维持的药理学方法
J Thromb Thrombolysis. 1999 Jan;7(1):33-8. doi: 10.1023/a:1008823202712.
10
Modulation of ventricular rate in permanent atrial fibrillation: randomized, crossover study of the effects of slow-release formulations of gallopamil, diltiazem, or verapamil.永久性心房颤动时心室率的调控：维拉帕米、地尔硫䓬或加洛帕米缓释制剂效果的随机交叉研究
Clin Cardiol. 1998 Nov;21(11):837-40. doi: 10.1002/clc.4960211110.
本文引用的文献
1
The time course during 36 weeks' endurance training of changes in Vo2 max. and anaerobic threshold as determined with a new computerized method.采用一种新的计算机化方法测定的36周耐力训练期间最大摄氧量（Vo2 max）和无氧阈变化的时间进程。
Clin Sci (Lond). 1984 Aug;67(2):229-36. doi: 10.1042/cs0670229.
2
Digitalis.洋地黄
N Z Med J. 1983 Apr 27;96(730):288-9.
3
Evidence of vagal neuropathy in chronic alcoholics.慢性酒精中毒患者迷走神经病变的证据。
Lancet. 1980 Nov 15;2(8203):1053-7. doi: 10.1016/s0140-6736(80)92275-8.
4
Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay.采用放射免疫分析法测定治疗性和中毒性血清地高辛浓度。
N Engl J Med. 1969 Nov 27;281(22):1212-6. doi: 10.1056/NEJM196911272812203.
5
Digoxin dosage and ventricular rate at rest and exercise in patients with atrial fibrillation.心房颤动患者静息及运动时的地高辛剂量与心室率
Acta Med Scand. 1971 Oct;190(4):321-33. doi: 10.1111/j.0954-6820.1971.tb07437.x.
6
An equation for prediction of energy expenditure of walking and running.
J Appl Physiol. 1973 May;34(5):559-63. doi: 10.1152/jappl.1973.34.5.559.
7
Human cardiovascular adjustments to exercise and thermal stress.人类心血管系统对运动和热应激的适应性调节。
Physiol Rev. 1974 Jan;54(1):75-159. doi: 10.1152/physrev.1974.54.1.75.
8
Beta-adrenergic blockade as adjunctive oral therapy in patients with chronic atrial fibrillation.β-肾上腺素能阻滞剂作为慢性房颤患者的辅助口服治疗方法。
Chest. 1977 May;71(5):592-6. doi: 10.1378/chest.71.5.592.
9
The beneficial effects of verapamil in chronic atrial fibrillation.维拉帕米在慢性心房颤动中的有益作用。
Arch Intern Med. 1979 Jul;139(7):747-9.
10
The use of digitalis glycosides in sinus rhythm.洋地黄苷在窦性心律中的应用。
Clin Sci Mol Med. 1978 Nov;55(5):417-21. doi: 10.1042/cs0550417.
Zotero 插件